OLGA FEDYUK: Open Payments
NPI 1457432759 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,816 in 59 payments from 13 companies in 2025. Trend: 2023 $202 · 2024 $937 · 2025 $1,816
Food & beverage: $1,816
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $485 |
| ABBVIE INC. | 18 | $458 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $224 |
| Madrigal Pharmaceuticals | 7 | $206 |
| Phathom Pharmaceuticals, Inc. | 2 | $139 |
| PFIZER INC. | 4 | $66 |
| Lilly USA, LLC | 2 | $60 |
| Ardelyx, Inc. | 2 | $47 |
| Celltrion USA Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, ENTYVIO, VOQUEZNA, LINZESS, MAVYRET, RINVOQ.
Industry payments across WA — which companies pay providers there.
